title: Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary.
abstract: We describe a patient with dysgerminoma who had elevated serum inhibin, tumor-associated trypsin inhibitor (TATI), and CA 125 concentrations, which increased progressively during follow-up of the advancing disease. Inhibin levels correlated closely with disease behavior. In contrast to inhibin, serum TATI and CA 125 failed to reveal the presence of silent disease.
authors.affiliation: Department of Obstetrics and Gynecology, University Hospital of Oulu, Oulu, Finland. msantala@cc.oulu.fi
authors.forename: M
authors.initials: M
authors.lastname: Santala
authors.forename: H
authors.initials: H
authors.lastname: Burger
authors.forename: A
authors.initials: A
authors.lastname: Ruokonen
authors.forename: F
authors.initials: F
authors.lastname: Stenbäck
authors.forename: A
authors.initials: A
authors.lastname: Kauppila
mesh_terms: D000328:Adult; D004407:Dysgerminoma / Q000097:blood*; D005260:Female; D006801:Humans; D007265:Inhibins / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood*; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000097:blood*
chemical_list: D014359:Trypsin Inhibitor, Kazal Pancreatic; D007265:Inhibins